Taipei Medical University

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Lin YL
------>authors3_c=???
------>paper_class1=1
------>Impact_Factor=1.241
------>paper_class3=2
------>paper_class2=1
------>vol=13
------>confirm_bywho=ncchang
------>insert_bywho=twchen
------>Jurnal_Rank=74.5
------>authors4_c=???
------>comm_author=1
------>patent_EDate=None
------>authors5_c=???
------>publish_day=1
------>paper_class2Letter=None
------>page2=293
------>medlineContent=
------>unit=E0109
------>insert_date=20081120
------>iam=7
------>update_date=None
------>author=???
------>change_event=6
------>ISSN=
------>authors_c=???
------>score=500
------>journal_name=Nephrology
------>paper_name=Chronic hepatitis ameliorates anaemia in haemodialysis patients.
------>confirm_date=20090805
------>tch_id=089049
------>pmid=18331433
------>page1=289
------>fullAbstract=BACKGROUND: Study for influence of chronic hepatitis (CH) on anaemia in haemodialysis (HD) patients remains inconclusive. We aim to characterize the red cell status between CH and hepatitis-free groups among the HD population. METHODS: We retrospectively analysed 80 chronic HD patients from Taipei Medical University Hospital with monthly sampled biochemical study between December 2004 and December 2005. Data classified according to the hepatitis-free, chronic hepatitis B and C groups were expressed as mean +/- standard deviation. Student~s t-test and anova were used to determine the mean difference for continuous variables. RESULTS: Age, Kt/V, systolic or diastolic blood pressure, body mass index, total cholesterol and triglyceride were not different between CH and hepatitis-free groups. HD duration (P = 0.0002), aspartate (P < 0.0001), alanine aminotransferase (P < 0.0001), alkaline phosphatase (P = 0.04), haemoglobin (P = 0.0066) and haematocrit (P = 0.002) were significantly more elevated in the CH group demanding less erythropoietin dose than in the hepatitis-free group. CONCLUSION: Our study demonstrated that lessened anaemia was observed in CH, which demanded less erythropoietin dose.
------>tmu_sno=None
------>sno=19439
------>authors2=Lin CW
------>authors3=Lee CH
------>authors4=Lai IC
------>authors5=Chen SS
------>authors6=Chen TW
------>authors6_c=???
------>authors=Lin YL
------>delete_flag=0
------>SCI_JNo=None
------>authors2_c=???
------>publish_area=0
------>updateTitle=Chronic hepatitis ameliorates anaemia in haemodialysis patients.
------>language=2
------>check_flag=None
------>submit_date=None
------>country=None
------>no=
------>patent_SDate=None
------>update_bywho=None
------>publish_year=2008
------>submit_flag=None
------>publish_month=6
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z